SG Americas Securities’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $825K | Buy |
|
|||||
|
2025
Q2 | $285K | Sell |
|
|||||
|
2025
Q1 | $46.8M | Buy |
|
|||||
|
2024
Q4 | $16.6M | Buy |
|
|||||
|
2024
Q3 | $416K | Sell |
|
|||||
|
2024
Q2 | $341K | Buy |
|
|||||
|
2024
Q1 | $126K | Sell |
|
|||||
|
2023
Q4 | $175K | Sell |
|
|||||
|
2023
Q3 | $968K | Buy |
|
|||||
|
2023
Q2 | $373K | Buy |
|
|||||
|
2023
Q1 | $248K | Buy |
|
|||||
|
2022
Q4 | $321K | Sell |
|
|||||
|
2022
Q3 | $548K | Sell |
|
|||||
|
2022
Q2 | $202K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.17M | Buy |
|
|||||
|
2021
Q2 | $583K | Sell |
|
|||||
|
2021
Q1 | $695K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $152K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $192K | Buy |
|